Sanara MedTech Inc. (SMTI) P/E Ratio History
Historical price-to-earnings valuation from 2017 to 2018
Loading P/E history...
SMTI Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Sanara MedTech Inc. (SMTI) trades at a price-to-earnings ratio of -4.4x, with a stock price of $19.08 and trailing twelve-month earnings per share of $-4.36.
The current P/E is 122% below its 5-year average of 20.1x. Over the past five years, SMTI's P/E has ranged from a low of 12.9x to a high of 30.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, SMTI trades at a 120% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, SMTI trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SMTI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SMTI P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $548M | 11.5 | - | +14% | |
| $433M | 5.1Lowest | - | +146%Best | |
| $5B | 712.1 | - | -48% | |
| $23B | 47.3 | 5.72Best | +2% | |
| $17B | 30.5 | - | -25% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
SMTI Historical P/E Data (2017–2018)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2018 Q3 | Sun Sep 30 2018 00:00:00 GM | $7.00 | $0.33 | 21.4x | +6% |
| FY2018 Q2 | Sat Jun 30 2018 00:00:00 GM | $7.00 | $0.35 | 20.1x | +0% |
| FY2018 Q1 | Sat Mar 31 2018 00:00:00 GM | $5.00 | $0.37 | 13.6x | -32% |
| FY2017 Q4 | Sun Dec 31 2017 00:00:00 GM | $6.00 | $0.47 | 12.9x | -36% |
| FY2017 Q3 | Sat Sep 30 2017 00:00:00 GM | $7.00 | $0.23 | 30.9x | +54% |
| FY2017 Q2 | Fri Jun 30 2017 00:00:00 GM | $8.00 | $0.37 | 21.7x | +8% |
Average P/E for displayed period: 20.1x
See SMTI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SMTI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SMTI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSMTI — Frequently Asked Questions
Quick answers to the most common questions about buying SMTI stock.
Is SMTI stock overvalued or undervalued?
SMTI trades at -4.4x P/E, below its 5-year average of 20.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does SMTI's valuation compare to peers?
Sanara MedTech Inc. P/E of -4.4x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is SMTI's PEG ratio?
SMTI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2017-2018.